Flexion Therapeutics Stock Price and Value Analysis

Should you buy Flexion Therapeutics stock? (NasdaqGM:FLXN). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Flexion Therapeutics to reach your target.

Target type
AdvantagesDisadvantagesNeutral
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the FLXN Numbers

FLXN Price
(Flexion Therapeutics stock price per share)
$24.91
[?] PE Ratio versus Sector 25% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Drug Manufacturers - General stocks
[?] Free Cash Flow Jitter 27%

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Flexion Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Flexion Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy FLXN Stock?

Does Flexion Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for Flexion Therapeutics to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.